Mutational Signature‐Based Biomarker for Phase <scp>II</scp> Trial of Olaparib Maintenance in Advanced High‐Grade Ovarian Cancer
Katsutoshi Oda(The University of Tokyo), Kosei Hasegawa(Saitama Medical University), Masataka Takenaka(Jikei University School of Medicine), Kunihiro Nishimura(National Cerebral and Cardiovascular Center), Keiko Ueda(Japan Society for the Promotion of Science), Yosuke Konno(Hokkaido University of Science), Daisuke Shintani(Saitama Medical University), Masahiro Kagabu(Iwate Medical University), Shiro Takamatsu(The University of Texas MD Anderson Cancer Center), Akira Nishijima(The University of Tokyo), Sho Sato(Saitama Medical University), Shoji Nagao(Hyogo Prefectural Cancer Center), Noriomi Matsumura(Kindai University Hospital), Takashi Aoki(X-Ability (Japan)), Kazuyoshi Kato(Kitasato University Hospital), Hiroyuki Aburatani(The University of Tokyo), Junzo Hamanishi(Kyoto University), Kosuke Yoshihara(Niigata University of Rehabilitation), M Mori(The University of Tokyo), Kenji Tatsuno(The University of Tokyo), Kosuke Kashiwabara(Japan Society for the Promotion of Science)
Cited by 0
Related Papers
Vegetarian Diets and Blood Pressure
|JAMA Internal Medicine|2014|524
Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism
|Circulation|2015|401
Predicting Coronary Heart Disease Using Risk Factor Categories for a Japanese Urban Population, and Comparison with the Framingham Risk Score: The Suita Study
|Journal of Atherosclerosis and Thrombosis|2014|227
PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
|Cancer Research|2008|193
Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
|Journal of Experimental & Clinical Cancer Research|2019|164